SEARCH

SEARCH BY CITATION

References

  • 1
    Feldmann M, Brennan FM, Chantry D, Haworth C, Turner M, Abney E, Buchan G, Barrett K, Barkley D, Chu A, Field M, Maini RN: Cytokine production in the rheumatoid joint: implications for treatment. Ann Rheum Dis 49: 480486, 1990
  • 2
    Firestein GS, Alvaro-Garcia JM, Maki R: Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 144: 33473353, 1990
  • 3
    Arend WP, Dayer JM: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 33: 305315, 1990
  • 4
    Dayer JM, de Rochemonteix B, Burrus B, Demczuk S, Dinarello CA: Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 77: 645648, 1986
  • 5
    Leizer T, Clarris BJ, Ash PE, van Damme J, Saklatvala J, Hamilton JA: Interleukin-1β and interleukin-1α stimulate the plasminogen activator activity and prostaglandin E2 levels of human synovial cells. Arthritis Rheum 30: 562566, 1987
  • 6
    Frisch SM, Ruley HE: Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J Biol Chem 262: 1630016304, 1987
  • 7
    Chin J, Rupp E, Cameron PM, MacNaul KL, Lotke PA, Tocci MJ, Schmidt JA, Bayne EK: Identification of a high-affinity receptor for interleukin 1α and interleukin 1β on cultured human rheumatoid synovial cells. J Clin Invest 82: 420426, 1988
  • 8
    Shirakawa F, Yamashita U, Chedid M, Mizel SB: Cyclic AMP—an intracellular second messenger for interleukin 1. Proc Natl Acad Sci U S A 85: 82018205, 1988
  • 9
    Chedid M, Shirakawa F, Naylor P, Mizel SB: Signal transduction pathway for IL-1: involvement of a pertussis toxin-sensitive GTP-binding protein in the activation of adenylate cyclase. J Immunol 142: 43014306, 1989
  • 10
    Munoz E, Beutner U, Zubiaga A, Huber BT: IL-1 activates two separate signal transduction pathways in T helper type II cells. J Immunol 144: 964969, 1990
  • 11
    Mary D, Aussel C, Pelassy C, Fehlmann M: IL-1 signaling for IL-2 production in T cells involves a rise in phosphatidylserine synthesis. J Immunol 141: 30783080, 1988
  • 12
    O'Neill LAJ, Bird TA, Saklatvala J: Interleukin 1 signal transduction. Immunol Today 11: 392394, 1990
  • 13
    Case JP, Lafyatis R, Kumkumian GK, Remmers EF, Wilder RL: IL-1 regulation of transin/stromelysin transcription in rheumatoid synovial fibroblasts appears to involve two antagonistic transduction pathways, an inhibitory, prostaglandin-dependent pathway mediated by cAMP, and a stimulatory, protein kinase C-dependent pathway. J Immunol 145: 37553761, 1990
  • 14
    Rosoff PM, Savage N, Dinarello CA: Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism. Cell 54: 7381, 1988
  • 15
    Wijelath ES, Kardasz AM, Drummond R, Watson J: Interleukin-one induced inositol phospholipid breakdown in murine macrophages: possible mechanism of receptor activation. Biochem Biophys Res Commun 152: 392397, 1988
  • 16
    Kester M, Simonson MS, Mené P, Sedor JR: Interleukin-1 generates transmembrane signals from phospholipids through novel pathways in cultured rat mesangial cells. J Clin Invest 83: 718723, 1989
  • 17
    Munoz E, Zubiaga AM, Sims JE, Huber BT: IL-1 signal transduction pathways. I. Two functional IL-1 receptors are expressed in T cells. J Immunol 146: 136143, 1991
  • 18
    Godfrey RW, Johnson WJ, Hoffstein ST: Recombinant tumor necrosis factor and interleukin-1 both stimulate human synovial cell arachidonic acid release and phospholipid metabolism. Biochem Biophys Res Commun 142: 235241, 1987
  • 19
    Godfrey RW, Johnson WJ, Newman T, Hoffstein ST: Interleukin-1 and tumor necrosis factor are not synergistic for human synovial fibroblast PLA2 activation and PGE2 production. Prostaglandins 35: 107114, 1988
  • 20
    Gilman SC, Chang J, Zeigler PR, Uhl J, Mochan E: Interleukin-1 activates phospholipase A2 in human synovial cells. Arthritis Rheum 31: 126130, 1988
  • 21
    Godfrey RW, Johnson WJ, Hoffstein ST: Interleukin-1 stimulation of phospholipase activity in rat synovial fibroblasts: possible regulation by cyclooxygenase products. Arthritis Rheum 31: 14211428, 1988
  • 22
    Jorgensen C, Angel J, Fournier C: Regulation of synovial cell proliferation and prostaglandin E2 production by combined action of cytokines. Eur Cytokine Network 2: 207215, 1991
  • 23
    Goodwin JS: Are prostaglandins proinflammatory, antiinflammatory, both or neither? J Rheumatol 18 (suppl 28): 2629, 1991
  • 24
    Eling T, Tainer B, Ally A, Warnock R: Separation of arachidonic acid metabolites by high-pressure liquid chromatography. Methods Enzymol 86: 511517, 1982
  • 25
    Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911917, 1959
  • 26
    Clark MA, Littlejohn D, Conway TM, Mong S, Steiner S, Crooke ST: Leukotriene D4 treatment of bovine aortic endothelial cells and murine smooth muscle cells in culture results in an increase in phospholipase A2 activity. J Biol Chem 261: 1071310718, 1986
  • 27
    Gronich JH, Bonventre JV, Nemenoff RA: Identification and characterization of a hormonally regulated form of phospholipase A2 in rat renal mesangial cells. J Biol Chem 263: 1664516651, 1988
  • 28
    Lapetina EG, Billah MM, Cuatrecasas P: The initial action of thrombin on platelets: conversion of phosphatidylinositol to phosphatidic acid preceding the production of arachidonic acid. J Biol Chem 256: 50375040, 1981
  • 29
    Wallach DP, Brown VJR: Studies on the arachidonic acid cascade. I. Inhibition of phospholipase A2 in vitro and in vivo by several novel series of inhibitor compounds. Biochem Pharmacol 30: 13151324, 1981
  • 30
    Carney DH, Scott DL, Gordon EA, LaBelle EF: Phosphoinositides in mitogenesis: neomycin inhibits thrombin-stimulated phosphoinositide turnover and initiation of cell proliferation. Cell 42: 479488, 1985
  • 31
    Augert G, Blackmore PF, Exton JH: Changes in the concentration and fatty acid composition of phospho-inositides induced by hormones in hepatocytes. J Biol Chem 264: 25742580, 1989
  • 32
    Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M: Synovium as a source of interleukin 6 in vitro: contribution to local and systemic manifestations of arthritis. J Clin Invest 83: 585592, 1989
  • 33
    Lyons-Giordano B, Davis GL, Galbraith W, Pratta MA, Arner EC: Interleukin-1β stimulates phospholipase A2 mRNA synthesis in rabbit articular chondrocytes. Biochem Biophys Res Commun 164: 488495, 1989
  • 34
    Kerr JS, Stevens TM, Davis GL, McLaughlin JA, Harris RR: Effects of recombinant interleukin-1 beta on phospholipase A2 activity, phospholipase A2 mRNA levels, and eicosanoid formation in rabbit chondrocytes. Biochem Biophys Res Commun 165: 10791084, 1989
  • 35
    Donati D, Baldari CT, Macchia G, Massone A, Telford JL, Parente L: Induction of gene expression by IL-1 in NIH 3T3 cells: possible requirement of protein kinase C activity and independence from arachidonic acid metabolism. J Immunol 145: 41154120, 1990
  • 36
    Vargaftig BB, Hai N Dao: Selective inhibition by mepacrine of the release of “rabbit aorta contracting substance” evoked by the administration of bradykinin. J Pharm Pharmacol 24: 159161, 1972
  • 37
    Erman A, Azuri R, Raz A: Phospholipase A2 inhibitors: differential inhibition of fatty acid acylation into kidney lipids by mepacrine and p-bromophenacyl bromide. Biochem Pharmacol 32: 20832087, 1983
  • 38
    Sterin-Speziale NB, Setton CP, Kahane VL, Speziale EH: Increase of phosphatidylinositol arachidonic acid incorporation induced by mepacrine. Biochem Pharmacol 38: 725728, 1989
  • 39
    Winkler JD, Sung C-M, Huang L: CoA-independent transacylase has characteristics distinct from those of PLA2 enzymes. Agents Actions 34: 103105, 1991
  • 40
    Nakazato Y, Simonson MS, Herman WH, Koniecz-kowski M, Sedor JR: Interleukin-1α stimulates prostaglandin biosynthesis in serum-activated mesangial cells by induction of a non-pancreatic (type II) phospholipase A2. J Biol Chem 266: 1411914127, 1991
  • 41
    Kramer RM, Checani GC, Deykin A, Pritzker CR, Deykin D: Solubilization and properties of Ca2+-dependent human platelet phospholipase A2. Biochim Biophys Acta 878: 394403, 1986
  • 42
    Colard O, Breton M, Pepin D, Chevy F, Bereziat G, Polonovski J: Arachidonate cannot be released directly from diacyl-sn-glycero-3-phosphocholine in thrombinstimulated platelets. Biochem J 259: 333339, 1989
  • 43
    Billah MM, Eckel S, Mullmann TJ, Egan RW, Siegel MI: Phosphatidylcholine hydrolysis by phospholipase D determines phosphatidate and diglyceride levels in chemotactic peptide-stimulated human neutrophils: involvement of phosphatidate phosphohydrolase in signal transduction. J Biol Chem 264: 1706917077, 1989
  • 44
    Dayer JM, Goldring SR, Robinson DR, Krane SM: Effects of human mononuclear cell factor on cultured rheumatoid synovial cells: interactions of prostaglandin E2 and cyclic adenosine 3′,5′-monophosphate. Biochim Biophys Acta 586: 87105, 1979
  • 45
    O'Neill LAJ, Barrett ML, Lewis GP: Induction of cyclo-oxygenase by interleukin-1 in rheumatoid synovial cells. FEBS Lett 212: 3539, 1987
  • 46
    Case JP, Maier JAM, Hla T, Sano H, Crofford IJ, Maciag T, Wilder RL: Complex regulation of cyclooxygenase mRNA levels and prostaglandin E2 production by cytokines and cAMP in rheumatoid synovial fibroblasts (abstract) Arthritis Rheum 33 (suppl 9): S17, 1990